Related Experiment Video
Updated: Jun 22, 2026
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
Published on: April 19, 2017
Can we use biomarkers and functional assays to implement personalized therapies in transplantation?
Birgit Sawitzki1, Andreas Pascher, Nina Babel
1Institute of Medical Immunology, Campus Charité Mitte, Charite University Medicine, Berlin, Germany. birgit.sawitzki@charite.de
Abstract:
Research in transplantation focuses on minimizing immunosuppression to decrease side effects and costs. Indeed, in some patients, partial or complete cessation of immunosuppression is successful, but currently we have no means of identifying suitable patients a priori. Current withdrawal protocols, which do not implement surrogate markers, carry a significant risk of graft injury. To minimize the risk, immune monitoring strategies are required. Here, we review recently described biomarkers and assays, which might enable identification of patients suitable for partial or complete weaning and patients at risk of rejection. The predictive power of these parameters has to be tested in prospective multicenter trials.
Insights
Identifying suitable transplant patients for reducing immunosuppression is crucial. New biomarkers and assays are reviewed to identify patients who can safely stop or reduce immunosuppressive drugs, minimizing rejection risk.
Area of Science:
- Immunology
- Transplantation Medicine
- Biomarker Discovery
Background:
- Minimizing immunosuppression in transplantation reduces side effects and costs.
- Current methods lack reliable predictors for successful immunosuppression withdrawal.
- Existing protocols carry a risk of graft injury due to the absence of surrogate markers.
Purpose of the Study:
- To review recently identified biomarkers and assays for immune monitoring in transplantation.
- To identify potential indicators for patients suitable for immunosuppression weaning.
- To highlight strategies for detecting patients at risk of graft rejection.
Main Methods:
- Literature review of recent biomarkers and assays in transplantation research.
- Analysis of immune monitoring strategies for immunosuppression management.
- Discussion of the potential application of identified markers in clinical practice.
Main Results:
- Several novel biomarkers and assays show promise for immune monitoring.
- These tools may help identify patients eligible for partial or complete immunosuppression cessation.
- Potential markers for predicting rejection risk have been described.
Conclusions:
- Biomarkers and assays are essential for safe immunosuppression management in transplant recipients.
- Further validation in prospective multicenter trials is required to confirm the predictive power of these parameters.
- Development of reliable immune monitoring strategies is key to personalized immunosuppression therapy.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...